AKRO - Akero Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
53.24
+1.22 (+2.35%)
At close: 04:00PM EDT
53.70 +0.46 (+0.86%)
After hours: 04:56PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close52.02
Open52.07
Bid53.40 x 800
Ask53.70 x 1400
Day's Range49.90 - 53.68
52 Week Range7.52 - 54.88
Volume963,116
Avg. Volume682,441
Market Cap2.946B
Beta (5Y Monthly)-0.94
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for AKRO

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more